Does zinc support immune tolerance by enhancing regulatory T cells and balancing cytokines?

Zinc status is a fundamental regulator of immune homeostasis, particularly in the context of immune tolerance and the prevention of autoimmune activity. Research consistently demonstrates that zinc influences the delicate balance between pro-inflammatory and regulatory immune responses.

Mechanisms of immune tolerance

Zinc acts as a signaling molecule that directly modulates the differentiation and function of T-cell subsets.

• Treg differentiation: Zinc promotes the maturation of naïve CD4+ T cells into Foxp3+ regulatory T cells (Tregs). This process is mediated by the zinc transporter ZIP10 (SLC39A10), which facilitates the intracellular zinc influx necessary for signaling.
• TGF-β/Smad signaling: Mechanistically, zinc enhances TGF-β1-dependent pathways. It increases the induction of phospho-Smad2/3, a critical step that drives FOXP3 expression—the master regulator of Treg development.
• Cytokine balance: Adequate zinc levels suppress the differentiation of pro-inflammatory Th1 and Th17 cells. By reducing IFN-γ and RORC2+ Th17 cell populations, zinc shifts the cytokine profile away from chronic inflammation toward a state of tolerance.
• Enzymatic regulation: Zinc may further support Treg maintenance by inhibiting Shp-1 at the T-cell receptor synapse, which amplifies IL-2/STAT5 signaling essential for Treg survival.

Clinical evidence and autoimmune activity

Low zinc status is strongly correlated with heightened autoimmune pathology and the presence of autoantibodies in human populations.

• Systemic associations: Meta-analyses encompassing over 26,000 participants show significantly lower serum zinc levels in patients with rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis.
• Autoantibody formation: Zinc deficiency is linked to the formation of specific autoantibodies, such as TPOAb and TgAb in thyroid disease and ZnT8A in type 1 diabetes. In thyroid disorders, zinc deficiency (<70 µg/dL) is associated with a nearly nine-fold increase in the odds of autoimmunity (OR: 9.3, 95% CI: 6.1–14.3).
• Age-related factors: In older adults, marginal zinc deficiency can exacerbate immunosenescence and oxidative stress, further compromising self-tolerance and promoting the development of autoantibodies.

Bottom line

Zinc is a critical micronutrient for maintaining immune tolerance by enhancing Treg function and balancing pro-inflammatory cytokines. Clinical evidence confirms that low zinc status is significantly associated with increased autoimmune activity and autoantibody production across multiple diseases.